MABEL MARTINEZ: Open Payments
NPI 1386314052 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 113 payments from 15 companies in 2025. Trend: 2023 $1,418 · 2024 $1,958 · 2025 $2,158
Food & beverage: $2,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $458 |
| Axsome Therapeutics, Inc. | 15 | $421 |
| Novartis Pharmaceuticals Corporation | 19 | $221 |
| Otsuka America Pharmaceutical, Inc. | 9 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $192 |
| Indivior Inc. | 4 | $131 |
| E.R. Squibb & Sons, L.L.C. | 5 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
Products named: VRAYLAR, Auvelity, REXULTI, CAPLYTA, LEQVIO, SUBLOCADE, COBENFY, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
